Galena Biopharma to Report Fourth Quarter and Year End 2015 Financial Results and Provide a Corporate Update on Thursday, March 10, 2016
26 févr. 2016 07h05 HE
|
Galena Biopharma, Inc.
SAN RAMON, Calif., Feb. 26, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology therapeutics...
Galena Biopharma Announces Proposed Settlement of Derivative Litigation
16 févr. 2016 17h00 HE
|
Galena Biopharma, Inc.
SAN RAMON, Calif., Feb. 16, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (the "Company"), (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of...
Galena Biopharma Announces Notice of Allowance of U.S. Patent for NeuVax™ (nelipepimut-S)
08 févr. 2016 07h05 HE
|
Galena Biopharma, Inc.
SAN RAMON, Calif., Feb. 08, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
Galena Biopharma to Present at the BIO CEO & Investor Conference
02 févr. 2016 07h05 HE
|
Galena Biopharma, Inc.
SAN RAMON, Calif., Feb. 02, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
Galena Biopharma Presents Observational Study Data in Gastric Cancer Patients at the ASCO 2016 Gastrointestinal Cancers Symposium
21 janv. 2016 16h10 HE
|
Galena Biopharma, Inc.
SAN RAMON, Calif., Jan. 21, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
Galena Biopharma Provides 2016 Outlook
13 janv. 2016 07h05 HE
|
Galena Biopharma, Inc.
SAN RAMON, Calif., Jan. 13, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
Galena Biopharma to Present at NobleCon12 - Noble Financial Capital Markets’ Twelfth Annual Investor Conference
11 janv. 2016 07h05 HE
|
Galena Biopharma, Inc.
SAN RAMON, Calif., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
Galena Biopharma Announces Pricing of Public Offering of Common Stock and Warrants
07 janv. 2016 09h25 HE
|
Galena Biopharma, Inc.
SAN RAMON, Calif., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
Galena Biopharma Announces Proposed Public Offering of Common Stock and Warrants
06 janv. 2016 16h25 HE
|
Galena Biopharma, Inc.
SAN RAMON, Calif., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
Galena Biopharma Announces a Change to Its Board of Directors
24 déc. 2015 07h05 HE
|
Galena Biopharma, Inc.
SAN RAMON, Calif., Dec. 24, 2015 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...